Activation of the PI3K/Akt/mTOR pathway, through PIK3CA amplifications, PIK3CA/PIK3R1/PIK3R2 mutations and PTEN mutations/loss of function, has also been linked to more aggressive EC tumor behavior (21–24). The gene discussed is MTOR; the disease is neoplasm.